Psychotherapy for Personality Disorders: Treatments and Evidence
Updated: 3 days ago
Author: Ukrainian Psychological Hub · Published: October 12, 2026 · Editorial Policy
Psychotherapy is a central treatment for personality disorders. A structured, collaborative course of psychological care can reduce persistent distress and disruptive patterns, strengthen identity and emotional regulation, and improve relationships and participation in everyday life. The appropriate approach depends on the person's clinical difficulties, goals, safety needs, other conditions, and access to treatment. Specialized psychotherapies have their strongest research base in borderline personality disorder (BPD); evidence for other personality disorders varies considerably. The American Psychiatric Association's 2024 practice guideline recommends an evidence-supported, structured psychotherapy directed at core BPD features, together with comprehensive person-centered planning.
For readers asking which therapy works best, the practical answer is that dialectical behavior therapy (DBT), mentalization-based treatment (MBT), schema therapy, transference-focused psychotherapy (TFP), structured clinical management, and appropriately adapted cognitive-behavioral approaches may all play a role. Their techniques, intensity, and evidence differ. Studies of one disorder cannot simply be transferred to another, and promising findings from a small or mixed sample do not establish a universal treatment hierarchy. This guide explains what each option actually does, how researchers evaluate it, where the evidence is strongest or preliminary, and how clinicians and patients make informed choices.
For the diagnostic overview and definitions underlying these clinical treatments, see Personality Disorders: Types, Symptoms, Diagnosis, and Treatment. This treatment guide focuses on psychotherapy research, treatment selection, and the practical organization of care.
What Does Psychotherapy Treat in Personality Disorders?
A personality disorder involves persistent, clinically significant difficulties in self-experience, interpersonal relationships, and ways of responding to situations, associated with distress or impairment. A personality trait is an ordinary pattern of thinking, feeling, or behaving. A maladaptive trait may contribute to difficulties, yet it does not by itself establish a disorder. A symptom is an experience or behavior occurring within a wider pattern. Screening may identify reasons to seek further evaluation; diagnosis requires professional assessment of history, duration, context, and impairment. These levels of description lead to different clinical questions, and a single personality questionnaire cannot supply a complete treatment plan.
The categorical framework of DSM-5-TR recognizes several named personality disorders. The alternative DSM personality disorder model focuses on impairments in identity, self-direction, empathy, and intimacy together with maladaptive traits. The WHO ICD-11 clinical diagnostic framework uses severity of personality dysfunction and relevant trait-domain qualifiers. These models help clinicians identify the function of a difficulty and its seriousness. Historic DSM Clusters A, B, and C remain useful descriptions of particular DSM groupings, but they do not organize all diagnoses in ICD-11 or determine which psychotherapy a person should receive.
Identity concerns the continuity and understanding of one's self-experience. Self-direction concerns the ability to establish and pursue personally meaningful goals. Empathy involves interpreting and responding to other people's experiences, and intimacy concerns sustaining close, reciprocal relationships. These capacities can be affected in different ways across clinical presentations. Therapy may help a person understand confusing shifts in self-image, remain engaged with long-term responsibilities, respond more flexibly when criticized, recognize another person's perspective, or maintain relationships without harmful patterns of control or withdrawal. Therapeutic success includes both relief from symptoms and improvements in what the person can actually do and sustain.
What Does Scientific Evidence Show?
The largest synthesis concerns borderline personality disorder. A 2020 Cochrane systematic review identified 75 randomized trials involving 4,507 participants across more than 16 psychotherapies. Compared with treatment as usual, psychotherapy improved the pooled measure of BPD symptom severity, with a standardized mean difference of approximately −0.52 in 22 trials and moderate-certainty evidence for that outcome. The review also examined self-harm, suicide-related outcomes, psychosocial functioning, and other symptoms, but many estimates were less certain, and statistical improvements were not always large enough to satisfy prespecified clinical-importance thresholds. Outcomes therefore need to be read separately rather than compressed into a promise that therapy always prevents crises.
Comparisons between bona fide psychological treatments often show improvements in multiple groups. A randomized trial of DBT versus general psychiatric management found substantial improvement in both carefully delivered treatments without establishing across-the-board superiority for DBT. Another recent review of psychotherapy for personality disorders observed that outcome studies for several historically defined Cluster A and Cluster C disorders are much scarcer than for BPD, and that evidence about optimal treatment intensity and length is incomplete. The often-repeated assertion that all personality disorders require many years of highly intensive therapy goes beyond what comparative studies have demonstrated.
Evidence quality depends on the size and selection of samples, random assignment, outcome measurement, treatment fidelity, therapist expertise, attrition, and length of follow-up. A trial involving recurrent self-injury may establish efficacy for that recruited population while saying much less about people who have the same diagnosis and have never self-injured. Trials may also compare a specialized therapy with an unusually strong clinical-management program, which can narrow between-group differences. Outcomes such as symptom severity, self-harm, hospitalization, treatment retention, social functioning, and quality of life measure related but distinct aspects of change. A rigorous clinical recommendation specifies which outcome and population its evidence supports.
Dialectical Behavior Therapy (DBT)
DBT is a structured behavioral treatment originally developed for persistent emotional and behavioral dysregulation, particularly in people experiencing repeated crises or high-risk behavior. In comprehensive programs it usually combines individual therapy, group skills training, clinically defined between-session coaching, and a consultation team for clinicians. Skills cover mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness. Therapists analyze the sequence of events, vulnerabilities, interpretations, feelings, and consequences around behavior, then help patients rehearse safer responses. The model integrates validation of understandable distress with deliberate work toward change.
Research supports DBT as an evidence-based option for BPD, especially when recurrent self-harm, intense affect, impulsivity, or crises are central targets. In the Cochrane review, DBT had favorable findings on some outcomes relative to treatment as usual, although certainty was lower for several secondary endpoints. A weekly skills group alone is not the same intervention as comprehensive DBT, so advertisements should specify which elements are actually provided. A patient may gain useful emotion-regulation skills without a BPD diagnosis, and a BPD diagnosis does not imply that every patient experiences self-injury or requires DBT above all alternatives.
For a focused explanation of the four-part program, skills, treatment duration, clinical trials, and practical questions, read Dialectical Behavior Therapy for BPD: How DBT Works and Evidence.
Mentalization-Based Treatment (MBT)
Mentalization is the capacity to understand one's own and others' behavior in relation to mental states such as emotions, beliefs, intentions, and uncertainty. Under interpersonal stress, people sometimes become unusually sure of interpretations that are incomplete or mistaken. MBT invites reflection on how an assumption emerged, how a relationship partner might see the event, and how strong feelings affect the ability to think clearly. In practice it often includes both individual and group sessions and close attention to the therapeutic relationship. A clinician helps maintain curiosity rather than supplying a supposedly definitive explanation of another person's motives.
MBT has a substantial specialized BPD literature, including randomized research and long-term follow-up reporting meaningful clinical benefits. Such findings support MBT as a credible treatment option but require attention to the original sample size, care comparison, and service conditions. Improvement in one outcome does not establish equal effects on employment, close relationships, or every clinical risk. MBT can be particularly relevant when misunderstanding of intentions, abrupt relational shifts, and difficulty maintaining perspective under emotional pressure interfere with functioning.
Schema Therapy
Schema therapy addresses persistent patterns through which people interpret themselves, others, and situations. Clinicians explore enduring beliefs and emotionally charged expectations, such as anticipating rejection, feeling unworthy, or needing perfect control to avoid criticism. Work may include cognitive reappraisal, experiential exercises, behavioral practice, and attention to how coping patterns become activated in the therapeutic relationship. A client who withdraws immediately after perceiving disapproval may learn to recognize the prediction, tolerate uncertainty, communicate more directly, and test different responses. Treatment links those changes to the person's history without assuming that one childhood event alone caused the disorder.
A 2014 multicenter randomized trial by Bamelis and colleagues tested schema therapy in patients with several personality disorders, including cluster C, paranoid, histrionic, and narcissistic presentations, and found advantages over clarification-oriented psychotherapy and usual care on the study's primary clinical outcomes. This is important evidence extending beyond BPD, but a combined diagnostic sample does not prove equally strong effects for each diagnosis. A 2024 trial of group schema therapy and group CBT in 154 people with both social anxiety disorder and avoidant personality disorder found substantial improvement in both groups, no significant difference in clinical outcome between groups at measured follow-ups, and higher treatment completion with schema therapy. That supports both interventions for the studied combined presentation while leaving other populations less certain.
Transference-Focused Psychotherapy (TFP)
TFP is a manualized psychodynamic therapy focused on persistent difficulties in self-understanding and relationships. It examines how representations of the self and others change across emotional states and how these patterns become visible in everyday life and therapy. A clinician may help someone recognize sharply polarized interpretations of a person as wholly supportive at one moment and entirely rejecting at another, then develop a more integrated view. The process uses a clear therapeutic frame and requires training in the model. The colloquial word “splitting” describes a possible psychological process and does not, by itself, constitute a diagnostic criterion or proof of BPD.
TFP has been evaluated in randomized BPD studies. Clarkin and colleagues' multiwave comparison found improvement across several active treatments with some outcome-specific differences. The research supports considering TFP when identity integration and persistent relational patterns are major concerns, while its comparative benefits cannot be generalized into an unconditional claim that TFP is the strongest psychotherapy for BPD or any other disorder. Treatment availability, expertise, patient preference, and consistency remain important.
Cognitive-Behavioral and Interpersonal Approaches
Adapted cognitive-behavioral therapy (CBT) identifies connections among interpretations, behavior, emotion, and real-world consequences. For personality-related dysfunction it may concentrate on recurring cycles across settings rather than a single symptom: avoidance of social contact, rigid perfectionism, impulsive reactions to criticism, assumptions about people's motives, or patterns that interfere with employment. Behavioral experiments, graded engagement, emotion-management skills, and more flexible problem-solving can make these patterns easier to change. Therapy must be adapted to the patient's pace, level of trust, capacities, and co-occurring conditions; a generic depression or anxiety CBT trial does not automatically demonstrate efficacy for personality disorder itself.
In avoidant personality disorder with social anxiety, the Baljé and colleagues trial directly supports a role for group CBT and schema therapy. For antisocial personality disorder, NICE recommends considering group-based cognitive and behavioral interventions directed at impulsivity, interpersonal problems, and antisocial behavior while noting that the evidence base remains limited. Structured interpersonal work can also help a person practice expressing needs, handling disagreement, setting boundaries, and retaining relationships. Research outcomes and risk management may differ across community, forensic, and outpatient settings, making population-specific interpretation essential.
Structured Clinical Management and General Psychiatric Management
High-quality care is more than the brand of a therapy. Structured clinical management and general psychiatric management provide a coherent account of the person's difficulties, a planned clinical relationship, practical problem-solving, clear crisis procedures, coordination of services, and attention to work, relationships, and daily functioning. They are meaningful active treatments rather than necessarily weak comparison conditions. In McMain and colleagues' randomized comparison, participants receiving general psychiatric management improved on important BPD-related outcomes alongside those receiving DBT. The finding underscores that organization, clinical competence, and continuity can be central mechanisms in good care.
An individualized care plan may legitimately integrate elements from several evidence-informed approaches. Still, an incoherent sequence of unrelated techniques can be difficult for patients to understand and for clinicians to evaluate. A treatment team should explain the working formulation, expected benefits, available alternatives, procedures during deterioration, and responsibilities for medication or comorbidity management. The 2024 APA guideline emphasizes collaborative, documented, person-centered planning for BPD. Treatment should remain understandable to the person receiving it, including when goals or service intensity change.
How Psychotherapy Differs Across Personality Disorders
Borderline Personality Disorder
BPD has the best-developed psychotherapy evidence base. DBT, MBT, schema therapy, TFP, and structured clinical management can be considered according to the person's goals, clinical presentation, prior treatment, and access. The APA guideline recommends an evidence-supported structured psychotherapy addressing core BPD features. The NICE BPD guideline also stresses the person's preference, degree of impairment, professional supervision, and broad monitoring of outcomes. The presence or absence of suicidal thoughts, self-harm, emotional lability, identity disturbance, or relational difficulty must be established for the individual rather than inferred from the diagnosis.
When recurrent self-harm or suicide risk is present, clinicians integrate collaborative risk assessment, safety planning, and appropriate crisis support with continued treatment. The risk deserves direct clinical attention, and a person is entitled to respectful care regardless of their history. Changes in friendships, work, housing, and sense of purpose are legitimate treatment priorities alongside symptom relief. Prospective research suggests many people experience meaningful symptomatic improvement, while functional recovery can take a different course; no person should be promised either inevitable decline or guaranteed rapid remission.
Avoidant Personality Disorder
Avoidant personality disorder involves pervasive insecurity, sensitivity to criticism or rejection, social inhibition, and substantial functional difficulties. A therapist may work on shame, anticipatory beliefs, gradual approach to feared situations, interpersonal flexibility, and opportunities for connection. CBT-based and schema-focused methods are plausible options, and the 2024 controlled study in co-occurring social anxiety and avoidant personality disorder provides relevant evidence for that specific population. Shyness, introversion, avoidant attachment, and a personality-disorder diagnosis represent different levels of description. An existing English Hub differential article explains the social-anxiety overlap more fully.
Narcissistic Personality Disorder
Psychotherapy for narcissistic personality disorder may work with unstable or rigid self-esteem regulation, sensitivity to evaluation, difficulty considering other perspectives, shame, interpersonal strain, and functioning. Therapists may use structured psychodynamic, schema-oriented, or other individualized methods while carefully developing a collaborative alliance. Robust diagnosis-specific comparative trials are limited. The multicenter schema therapy study included a narcissistic personality disorder subgroup within a broader sample but does not establish a unique best treatment for this diagnosis. The common word “narcissist” and internet phrase “covert narcissism” are not equivalent to a clinical diagnosis.
A clinician cannot diagnose someone from isolated behavior described by a partner or former partner. Harmful conduct deserves practical responses and accountability whether or not the person has any diagnosis. If a person is concerned about intimidation, coercion, or violence, their safety, access to support, and freedom to set boundaries are immediate priorities. A therapeutic formulation must be based on direct professional evaluation and should never serve as a blanket excuse for actions that harm others.
Antisocial Personality Disorder
For antisocial personality disorder (ASPD), care may focus on recurrent harmful behavior, difficulty with cooperation, impulsivity, practical instability, and relevant co-occurring conditions. The formal diagnosis is distinct from the research and forensic construct psychopathy and from the informal term “sociopath.” Goals often need to be observable and negotiated: fewer conflicts, less aggressive behavior where present, improved responsibility, better problem-solving, and sustained engagement with education, housing, or work. Risk assessment must be proportionate to actual behavior and circumstances rather than stereotypes.
The NICE ASPD guideline advises considering structured group cognitive and behavioral interventions in appropriate settings, using positive engagement rather than exclusion or punitive attitudes, and treating co-occurring mental disorders. The guideline explicitly recognizes limited direct evidence. Programs developed for offending behavior cannot automatically be treated as established cures for ASPD in the general population. Treatment planning should also evaluate substance use, medication misuse risk, and the safety of everyone affected, using multidisciplinary coordination when necessary.
Obsessive-Compulsive Personality Disorder
Obsessive-compulsive personality disorder (OCPD) involves pervasive patterns such as inflexible perfectionism, control, orderliness, and difficulty adapting when these lead to substantial impairment. Treatment may address excessively rigid rules, delegation, interpersonal tension, uncertainty tolerance, and the practical costs of perfectionism. Disorder-specific controlled trials are fewer than for BPD; conclusions should remain appropriately modest. OCPD is clinically distinct from obsessive-compulsive disorder (OCD), which is characterized by obsessions and compulsions and has its own treatment evidence. The present article focuses on psychotherapy choices across personality disorders rather than competing with an existing OCPD-versus-OCD comparison intent.
Dependent, Paranoid, Schizoid, Schizotypal, and Other Presentations
Other clinical presentations call for similarly individualized work. Relevant goals may include increasing autonomous decision-making, working with pervasive mistrust, understanding social disconnection, addressing distress associated with unusual experiences, or improving interpersonal flexibility. Co-occurring anxiety, depression, trauma-related conditions, psychosis, or neurodevelopmental differences may require dedicated care. The 2025 clinical evidence review documents the relative scarcity of strong treatment studies for several conditions. A clinician should explain when recommendations rest on direct trials, studies of mixed samples, broader psychological principles, or expert clinical judgment. The underlying disorder's name alone is insufficient to make the treatment choice.
Clinical Assessment Before Treatment
A careful assessment traces the history of the difficulties, their onset and persistence, areas of impairment, past care, current symptoms, strengths, social support, stressors, cultural context, medications, physical health, and possible risks. Structured interviews and standardized questionnaires can contribute useful data, yet a screening score is not a diagnosis. Clinicians consider both categorical diagnoses and the degree of dysfunction in self and interpersonal life. The WHO's ICD-11 clinical diagnostic requirements offer authoritative standards for professional identification, rather than a checklist intended for self-diagnosis.
Differential diagnosis matters because related symptoms can arise from bipolar mood episodes, PTSD, dissociative disorders, anxiety, OCD, ADHD, autism, depression, substance effects, medical illness, or acute environmental stress. A person can also have more than one relevant condition. The history of mood episodes must be distinguished from long-standing patterns of interpersonal functioning; our bipolar disorder versus BPD article addresses that clinical question. Dissociative symptoms also require direct investigation; our DID versus BPD article treats one related differential. The right psychotherapy may depend on the broader formulation, including conditions that need simultaneous evidence-based care.
Culture influences how autonomy, respect, intimacy, conflict, and expressions of emotion are understood. Trauma exposure and discrimination can shape present expectations, but neither automatically explains a personality disorder nor should be ignored. Clinicians should assess language preference, disability-related needs, financial barriers, age, family relationships, caregiving responsibilities, and the safety of the current environment. A respectful assessment supports a stronger therapeutic relationship and helps distinguish clinical dysfunction from behavior that is understandable in context.
Choosing a Psychotherapy: A Clinical Decision Process
The first priority is an agreed formulation of what needs to change. When dangerous behaviors or acute crises are present, immediate safety and stabilization need attention. When avoidance dominates functioning, gradual behavioral and relational engagement may be central. Some people want to improve identity coherence, emotional insight, or capacity for intimacy; others need practical help maintaining work or parenting responsibilities. The chosen method should address those goals and be available at a feasible intensity. A treatment delivered well, with appropriate training, can be more useful than a prestigious label attached to a service that lacks the actual program components.
Patients can ask whether the treatment is manualized, what evidence applies to their diagnosis, whether a therapist has training and supervision, how individual and group sessions are organized, what happens during a crisis, and how change is monitored. It is appropriate to discuss expected duration, fees, insurance, transportation, privacy, accessibility, alternative formats, and the impact on daily life. The choice should be revisited if the person's goals or clinical circumstances change. APA and NICE support collaborative planning with attention to preferences and clinical needs.
Treatment Duration and Intensity
Personality-disorder psychotherapy often extends over months or longer, yet no single number of sessions is suitable for everyone. Study programs vary widely in duration and intensity, and more sessions do not automatically mean more benefit for every person. The 2025 research review found insufficient convincing comparative evidence that long, intensive therapy universally outperforms shorter, less intensive approaches. A treatment's coherence, appropriateness, alliance, and opportunity to practice skills in daily life may be as important as calendar length.
The NICE BPD guideline advises against interventions shorter than three months specifically intended to treat BPD outside an appropriately structured service. This condition-specific caution should not be generalized to every personality disorder. The time needed also changes with comorbidity, housing instability, safety needs, access to group treatment, and the goals the person hopes to achieve. Duration and intensity can be reviewed collaboratively, including whether step-down care, periodic follow-up, or continued specialist support is appropriate.
Measuring Progress, Setbacks, and Recovery
Progress is best measured against goals important to the person and the clinician's assessment of clinically meaningful change. Useful indicators include emotional distress, repeated problem behaviors, interpersonal conflicts, avoidance, crisis-service use where relevant, work and education participation, relationship stability, independent decision-making, and daily functioning. Validated measures can assist consistent review over time, but no single rating score captures recovery. A patient may improve on a symptom scale while still needing practical or relational support, or may achieve better functioning before symptom measures show large changes.
Longitudinal data caution against treating personality disorders as permanent life sentences. Zanarini and colleagues' 16-year prospective study distinguished symptomatic remission from recovery involving broader vocational and social functioning. Group trajectories cannot predict an individual's future, and naturalistic follow-up does not attribute every improvement to a specific therapy. Treatment plans should recognize incremental achievements as well as setbacks, which can reflect new stress, treatment mismatch, or unmet needs. A sudden or sustained worsening deserves professional reassessment rather than a judgment that the person has failed treatment.
Medication and Coordinated Care
Psychotherapy addresses core patterns of personality functioning; medication may be useful for a separately diagnosed condition or a carefully defined, monitored symptom target. For BPD, the 2024 APA guideline places structured psychotherapy at the center of care and advises that medication specifically targeting BPD be adjunctive, time-limited, and directed at a measurable symptom. The NICE BPD guideline cautions against medication solely for the disorder's core symptoms and against medium- or long-term antipsychotics specifically for BPD. These recommendations differ from treatment for co-occurring major depression, bipolar disorder, or another condition with separate medication evidence.
The NICE ASPD guideline does not recommend routine medication to treat ASPD or associated anger, aggression, and impulsivity. Prescribing decisions require medical evaluation of adverse effects, interactions, overdose or misuse risks when relevant, and the practical ability to monitor treatment. A patient should discuss changes with a prescriber rather than abruptly stopping medication. Case management, occupational support, substance-use services, physical health care, crisis resources, and family or social support can also contribute to functioning. Coordinated care is especially important when several clinicians or services are involved.
Risks and Limitations of Psychotherapy
Psychotherapy can be emotionally demanding, and treatment quality varies. Problems can arise from diagnostic error, an ill-fitting approach, vague goals, inadequate management of risk, boundary violations, invalidating encounters, poorly coordinated services, or pressure to continue a therapy that is not helping. Published trials sometimes give incomplete information about adverse effects and may underrepresent particular demographic groups or people with complex comorbidity. The Cochrane synthesis noted limitations in available adverse-event reporting. These gaps should inform consent and monitoring without discouraging appropriate care.
When improvement stalls, the clinician and patient can revisit the assessment, look for co-occurring conditions, check whether the treatment was actually delivered as intended, review financial and scheduling barriers, and adjust goals or the level of care. Changing modalities may help, but so may better access, supervision, continuity, and crisis planning. A personality-disorder diagnosis must never become a reason to exclude someone from care; NICE clinical guidance specifically rejects that practice for ASPD. Clinical language should communicate treatable patterns of difficulty rather than a fixed judgment about anyone's character or value.
How to Find Suitable Help
A person considering therapy can begin with a licensed mental-health professional experienced in assessing personality-related difficulties. Useful questions include which models the clinician practices, what qualifications and supervision they have, which symptoms and functional goals they would prioritize, how progress is measured, and how they work with co-occurring conditions. The person may bring a timeline of concerns, prior treatment experiences, medication information, relevant life events, and two or three personally meaningful goals. Asking for clarification of a diagnosis or a second opinion is reasonable.
When specialist programs are scarce, discuss structured general psychiatric management, community mental-health services, supervised group treatment, university training clinics, and telehealth where clinically appropriate. Availability and cost can influence adherence and outcomes. Online self-tests or commercial chatbot services cannot replace structured clinical evaluation, professional accountability, and a safety plan. If current circumstances include coercion or abuse, treatment should also consider practical protection and external support. Privacy, accessibility, and the person's choice deserve serious attention.
When there is imminent danger, rapidly escalating suicidal intent, serious self-injury, or a credible immediate threat to someone else, seek urgent local emergency or crisis assessment rather than waiting for a routine therapy session. Safety and ongoing psychotherapy belong within a coordinated plan. People who have experienced a crisis deserve continued, respectful follow-up and access to evidence-informed care after the immediate emergency is addressed.
Frequently Asked Questions
Can personality disorders improve with psychotherapy?
Yes. Structured psychotherapy can improve symptoms and real-world functioning, although the strength of evidence varies by diagnosis and method. The Cochrane review shows treatment benefits in BPD compared with treatment as usual, while long-term observational studies illustrate that meaningful recovery is possible. No outcome is guaranteed for a particular person, and progress should be assessed across the individual's life rather than a single symptom.
What is the best therapy for borderline personality disorder?
There is no established universal winner. DBT, MBT, schema therapy, TFP, and structured clinical approaches are valid options depending on clinical goals and access. A 2025 secondary analysis of DBT and schema therapy identified some short-term differences across patient subgroups, but these differences did not persist at follow-up and do not constitute a validated algorithm for assigning every patient to a modality.
Is DBT only used for BPD?
No. DBT skills and adapted approaches may be used for other clinical concerns, but efficacy must be evaluated separately for each population and format. Attending DBT does not establish that someone has BPD, and being diagnosed with BPD does not require a specific symptom such as self-harm.
Can therapy help narcissistic personality disorder?
Psychotherapy may address self-esteem regulation, difficulties in empathy, persistent conflict, shame, and impaired functioning. Disorder-specific high-quality comparative trials are limited, so confident rankings among modalities are premature. The schema therapy study involving several personality disorders contributes bounded evidence. Treatment should be based on an actual clinical assessment, not a label supplied by an observer.
Is antisocial personality disorder treatable?
People with ASPD can receive psychological treatment and practical support aimed at reducing problematic behavior and improving functioning. The clinical evidence is limited, and programs vary. NICE recommends considering group cognitive and behavioral interventions and treating co-occurring conditions rather than excluding patients because of a diagnosis.
Is avoidant personality disorder the same as social anxiety or avoidant attachment?
No. These experiences can overlap, but they represent different concepts and diagnostic questions. The 2024 randomized trial evaluated a sample with both avoidant personality disorder and social anxiety, so it cannot settle every case. The Hub's English differential review discusses the distinction and its clinical implications.
How many months of psychotherapy will I need?
There is no universal duration. Treatment is determined by complexity, practical access, ongoing goals, and response. Some programs last months; others are longer. A reasonable plan specifies when the clinician and patient will review progress and consider changes to intensity or approach. The 2025 evidence review argues against assuming that more intensive and longer care is always better.
Can an online test select my treatment?
No. A screening score can flag concerns but cannot establish personality-disorder diagnosis, differential diagnosis, safety needs, or the appropriate psychotherapy. The distinction between normative traits and clinical disorders is described in our article on neuroticism and personality disorders. Qualified assessment remains essential.
Will medication cure a personality disorder?
Medication is not established as a universal cure for core personality dysfunction. It may be appropriate for co-occurring disorders or carefully defined target symptoms. The 2024 APA BPD guideline emphasizes psychotherapy as primary treatment and cautions about how symptom-targeted medication is used. Decisions should be made with the prescribing clinician.
What if therapy is making things worse?
Tell the clinician what has changed, ask for a review of pace, fit, boundaries, and any missed conditions, and consider a second opinion if concerns remain unresolved. New risk of self-harm, suicide, or violence requires prompt professional assessment. The patient should know how to access help between sessions where clinically indicated.
Related Articles
For a detailed explanation of the BPD-specific clinical process and comparative treatment evidence, see Transference-Focused Psychotherapy for BPD: Evidence and Process.
Borderline Personality Disorder: Symptoms, Diagnosis, and Treatment — the condition-specific clinical overview for the disorder with the largest psychotherapy research base.
Personality Disorders vs Personality Traits: Clinical Differences — distinguishing clinical impairment from normative personality differences.
Bipolar Disorder vs Borderline Personality Disorder: How Clinicians Distinguish Them — how episodes and enduring clinical patterns are assessed differently.
Social Anxiety vs Avoidant Personality Disorder: Overlap and Differences — a related differential with direct implications for psychotherapy planning.
DID vs Borderline Personality Disorder: Symptoms and Diagnostic Differences — evaluating dissociative experiences and longstanding relational symptoms.
Neuroticism and Personality Disorders: Dimensional Traits and Clinical Diagnosis — understanding why trait scores do not make a diagnosis.
For prescribing guidance across different personality disorders, see Are Medications Used for Personality Disorders? Clinical Guidance.
Treatment for Narcissistic Personality Disorder: Therapy and Evidence — NPD-specific therapy evidence and limits beyond general personality-disorder outcomes.
For evidence about remission, long-term prognosis, and how symptoms differ from social and vocational recovery, read Personality Disorders: Long-Term Outcomes and Recovery.